Aveanna Healthcare Holdings Inc , a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States.
infoAveanna Healthcare is a small cap stock with a total market cap of 297.06M.
infoThey trade on the NASDAQ and had their IPO 2 years and 3 months ago.
infoAveanna Healthcare currently employs 33700 people.
infoAs of Wednesday, Aug 23 2023, Aveanna Healthcare’s share price is $1.56.
News Relating to Aveanna Healthcare
Zacks Investment Research
Aveanna Healthcare (AVAH) Reports Q2 Loss, Tops Revenue Estimates
Thursday Aug 10 2023 at 09:15
Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.03 per share a year ago.
GlobeNewsWire
Aveanna Announces Second Quarter 2023 Earnings Release Date and Conference Call
Thursday Jul 20 2023 at 06:00
ATLANTA, July 20, 2023 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 10, 2023, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2023 Earnings Call Transcript
Friday May 12 2023 at 13:20
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q1 2023 Earnings Conference Call May 11, 2023 10:00 AM ET Company Participants Shannon Drake – Chief Legal Officer Jeff Shaner – Chief Executive Officer Dave Afshar – Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies Kieran Ryan – Deutsche Bank A.J. Rice – Credit Suisse Joanna Gajuk – Bank of America Scott Fidel – Stephens Inc. Operator Good morning, and welcome to the Aveanna Healthcare Holdings First Quarter 2023 Earnings Conference Call.
Zacks Investment Research
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
Thursday May 11 2023 at 09:10
Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.04 per share a year ago.
GlobeNewsWire
Aveanna Announces First Quarter 2023 Earnings Release Date and Conference Call
Monday Apr 24 2023 at 06:00
ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 11, 2023, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
GlobeNewsWire
Aveanna Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call
Monday Feb 27 2023 at 16:05
ATLANTA, Feb. 27, 2023 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 16, 2023, to be followed by a conference call at 10 a.m. (Eastern Time) on the same day.
Zacks Investment Research
New Strong Sell Stocks for January 12th
Thursday Jan 12 2023 at 09:47
APP, ACIW and ABM have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2023.
Zacks Investment Research
New Strong Sell Stocks for January 9th
Monday Jan 09 2023 at 09:02
ADTN, AVAH and DBI have been added to the Zacks Rank #5 (Strong Sell) List on January 9, 2023.
Zacks Investment Research
New Strong Sell Stocks for January 4th
Wednesday Jan 04 2023 at 09:02
AVAH, CBRL and ILMN have been added to the Zacks Rank #5 (Strong Sell) List on January 4, 2023.
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2022 Earnings Call Transcript
Saturday Nov 12 2022 at 14:42
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Shannon Drake – Chief Legal Officer and Corporate Secretary Tony Strange – President and Chief Executive Officer Jeff Shaner – Chief Operating Officer David Afshar – Chief Financial Officer Conference Call Participants Taji Phillips – Jefferies Joanna Gajuk – Bank of America Pito Chickering – Deutsche Bank Ben Hendrix – RBC Operator Good morning, and welcome to Aveanna Healthcare Holdings Third Quarter 2022 Earnings Conference Call. Today’s call is being recorded and we have allocated one hour for prepared remarks and Q&A.
GlobeNewsWire
Aveanna Announces Third Quarter 2022 Earnings Release Date and Conference Call
Tuesday Oct 25 2022 at 16:05
ATLANTA, Oct. 25, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results after the market close on Wednesday, November 9, 2022, to be followed by a conference call on Thursday, November 10, 2022 at 10:00 a.m. (Eastern Time).
Seeking Alpha
Aveanna Healthcare – In Need Of Help
Monday Sep 26 2022 at 02:04
Aveanna Healthcare has seen dismal share price performance in its first year after its public offering. Too high leverage, ambitions, inflation, and adjusted earnings are to blame for this.
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q2 2022 Results – Earnings Call Transcript
Saturday Aug 13 2022 at 21:20
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Shannon Drake – Chief Legal Officer and Corporate Secretary Rod Windley – Executive Chairman Tony Strange – Chief Executive Officer and President David Afshar – Chief Financial Officer Jeff Shaner – Chief Operating Officer Conference Call Participants Joanna Gajuk – Bank of America Brian Tanquilut – Jefferies Matt Borsch – BMO Capital Markets A.J. Rice – Credit Suisse Sarah James – Barclays Pito Chickering – Deutsche Bank Ben Hendrix – RBC Capital Markets Operator Good morning and welcome to Aveanna Healthcare Holdings Second Quarter 2022 Earnings Conference Call.
Zacks Investment Research
Aveanna Healthcare (AVAH) Q2 Earnings and Revenues Miss Estimates
Wednesday Aug 10 2022 at 21:49
Aveanna (AVAH) delivered earnings and revenue surprises of -50% and 3.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q1 2022 Results – Earnings Call Transcript
Thursday May 12 2022 at 17:55
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q1 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Shannon Drake – Chief Legal Officer & Corporate Secretary Tony Strange – President & CEO Jeff Shaner – Chief Operating Officer Dave Afshar – CFO Conference Call Participants Matt Borsch – BMO Capital Markets Joanna Gajuk – Bank of America Pito Chickering – Deutsche Bank Brian Tanquilut – Jefferies Sarah James – Barclays A.J. Rice – Credit Suisse Ben Hendrix – RBC Capital Markets John Ransom – Raymond James Operator Good morning and welcome to Aveanna Healthcare Holdings’ First Quarter 2022 Earnings Conference Call.
Zacks Investment Research
Aveanna Healthcare (AVAH) Q1 Earnings Lag Estimates
Wednesday May 11 2022 at 18:49
Aveanna (AVAH) delivered earnings and revenue surprises of -33.33% and 4.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewsWire
Aveanna to Participate at the RBC Capital Markets Global Healthcare Conference
Tuesday May 10 2022 at 08:00
ATLANTA, May 10, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 17, 2022.
GlobeNewsWire
Aveanna Announces First Quarter 2022 Earnings Release Date and Conference Call
Thursday Apr 21 2022 at 08:00
ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results after the market close on Wednesday, May 11, 2022, to be followed by a conference call on Thursday, May 12, 2022 at 10:00 a.m. (Eastern Time).
The Motley Fool
Why Aveanna Healthcare Stock Got Sick Again Today
Thursday Mar 31 2022 at 18:49
The analyst price target cuts just keep coming for the loss-making company.
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q4 2021 Results – Earnings Call Transcript
Tuesday Mar 29 2022 at 13:23
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q4 2021 Results – Earnings Call Transcript
The Motley Fool
Why Aveanna Healthcare Stock Is Crashing Today
Tuesday Mar 29 2022 at 12:26
The home health company missed analysts’ estimates with its Q4 results.
Benzinga
Here’s Why Aveanna Healthcare Shares Are Falling
Tuesday Mar 29 2022 at 10:58
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) shares are trading lower by 26.2% at $3.98 after the company reported FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates.
GlobeNewsWire
Aveanna to Participate at Upcoming Investor Conferences
Tuesday Mar 01 2022 at 16:09
ATLANTA, March 01, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will virtually attend the following investor conferences:
GlobeNewsWire
Aveanna Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call
Tuesday Mar 01 2022 at 16:06
ATLANTA, March 01, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that the company will release its fourth quarter and full year results after the market close on Monday, March 28, 2022, to be followed by a conference call on Tuesday, March 29, 2022 at 10:00 a.m. (Eastern Time).
GlobeNewsWire
Aveanna to Participate at Upcoming Investor Conferences
Friday Nov 19 2021 at 08:00
ATLANTA, Nov. 19, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will virtually attend the following investor conferences:
Seeking Alpha
Aveanna Healthcare Holdings Inc.’s (AVAH) CEO Tony Strange on Q3 2021 Results – Earnings Call Transcript
Tuesday Nov 16 2021 at 16:17
Aveanna Healthcare Holdings Inc.’s (AVAH) CEO Tony Strange on Q3 2021 Results – Earnings Call Transcript
Zacks Investment Research
AVAH vs. ELAN: Which Stock Is the Better Value Option?
Wednesday Oct 20 2021 at 13:59
AVAH vs. ELAN: Which Stock Is the Better Value Option?
Seeking Alpha
Aveanna Healthcare: Compelling Longer-Term Growth Story Remains Intact
Tuesday Sep 14 2021 at 13:18
Aveanna Healthcare continues to outperform through the pandemic, backed by the resilience of its core Pediatric business. The favorable rate backdrop also looks set to be sticky throughout the remainder of the year, supporting the near term outlook.
Seeking Alpha
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q2 2021 Results – Earnings Call Transcript
Friday Aug 13 2021 at 12:04
Aveanna Healthcare Holdings Inc. (AVAH) CEO Tony Strange on Q2 2021 Results – Earnings Call Transcript
GlobeNewsWire
Aveanna Announces Second Quarter 2021 Earnings Release Date and Conference Call
Thursday Jul 08 2021 at 16:05
ATLANTA, July 08, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that the company will release its second quarter results after the market close on Wednesday, August 11, 2021, to be followed by a conference call on Thursday, August 12, 2021 at 10:00 a.m. (Eastern Time).
Aveanna Healthcare Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Aveanna Healthcare’s Altman Z-score is 0.35 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.
Derived from SEC.GOV filing dataopen_in_new
Aveanna Healthcare Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 1 insider has bought $19.65K of common stock in Aveanna Healthcare on the stock market with no insider selling.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Aveanna Healthcare’s Income Quality of -1.39 is lower than its Industry Group of 1.19 (-216.8% lower)
Aveanna Healthcare’s Income Quality of -1.39 is lower than its Major Industry Group of 0.51 (-372.5% lower)
Aveanna Healthcare’s Income Quality of -1.39 is lower than its Sector of 0.5 (-378.0% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Aveanna Healthcare’s Current Ratio of 0.85 is lower than its Industry Group of 1.24 (-31.5% lower)
Aveanna Healthcare’s Current Ratio of 0.85 is lower than its Major Industry Group of 1.56 (-45.5% lower)
Aveanna Healthcare’s Current Ratio of 0.85 is lower than its Sector of 1.59 (-46.5% lower)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-1.35 & 27.26)
Cannot compare a negative PE Ratio (-1.35 & -0.48)
Cannot compare a negative PE Ratio (-1.35 & -0.29)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Cannot compare a negative PB Ratio (-64.55 & 2.2)
Cannot compare a negative PB Ratio (-64.55 & 1.42)
Cannot compare a negative PB Ratio (-64.55 & 1.88)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Aveanna Healthcare’s ROE of 47.78 is greater than its Industry Group of 0.08 (59625.0% greater)
Aveanna Healthcare’s ROE of 47.78 is greater than its Major Industry Group of -0.21 (22852.4% greater)
Aveanna Healthcare’s ROE of 47.78 is greater than its Sector of -0.04 (119550.0% greater)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Aveanna Healthcare’s ROCE of 0.04 is in line with its Industry Group of 0.04
Aveanna Healthcare’s ROCE of 0.04 is greater than its Major Industry Group of -0.23 (117.4% greater)
Aveanna Healthcare’s ROCE of 0.04 is greater than its Sector of -0.02 (300.0% greater)
Derived from SEC.GOV filing dataopen_in_new